2024 ICD-10-CM Diagnosis Code Q69.9

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Absent tibia, polydactyly, arachnoid cyst syndrome
• Arachnoid cyst
• Autosomal dominant polycystic kidney disease
• Autosomal dominant preaxial polydactyly, upper back hypertrichosis syndrome
• Brain malformation, congenital heart disease, postaxial polydactyly syndrome
• Congenital abnormal shape of rib
• Congenital anomaly of lobe of ear
• Congenital dilatation of colon
• Congenital hypoplasia of tibia
• Congenital lymphangiectasia
• Congenital malformation of the meninges
• Congenital pectus excavatum
• Cortical blindness
• Cortical blindness, intellectual disability, polydactyly syndrome
• Dandy-Walker malformation with postaxial polydactyly syndrome
• Dandy-Walker syndrome
• Deformity of sternum
• Ectrodactyly polydactyly syndrome
• Finger hyperphalangy, toe anomalies, severe pectus excavatum syndrome
• Hereditary disorder of lymphatic system
• Hexadactyly
• Hirschsprung disease with deafness and polydactyly syndrome
• Holoprosencephaly and postaxial polydactyly syndrome
• Holzgreve syndrome
• Hyperphalangy
• Hyperphalangy
• Hypoplastic tibia and postaxial polydactyly syndrome
• Intellectual disability, polydactyly, uncombable hair syndrome
• Macroencephaly
• McKusick Kaufman syndrome
• Megalencephaly, polymicrogyria, postaxial polydactyly, hydrocephalus syndrome
• Micromelia
• Mirror polydactyly, vertebral segmentation and limb defect syndrome
• Mirror-image polydactyly
• Mullerian remnant
• Multinodular goiter
• Multinodular goiter, cystic kidney, polydactyly syndrome
• Oliver syndrome
• Pectus deformity of chest
• Pectus excavatum
• Persistent Mullerian derivative with lymphangiectasia and polydactyly syndrome
• Polydactyly
• Polydactyly myopia syndrome
• Postaxial polydactyly, anterior pituitary anomalies, facial dysmorphism syndrome
• Postaxial polydactyly, dental, vertebral anomalies syndrome
• Potter's facies
• Preaxial polydactyly, colobomata, intellectual disability syndrome
• Renal agenesis
• Scalp defect postaxial polydactyly syndrome
• Sensorineural hearing loss of bilateral ears
• Short rib dysplasia
• Short rib dysplasia
• Short rib dysplasia
• Short rib dysplasia
• Short rib dysplasia
• Short rib polydactyly syndrome
• Short rib polydactyly syndrome Saldino Noonan type
• Short rib-polydactyly syndrome, Majewski type
• Split foot
• Split-foot malformation, mesoaxial polydactyly syndrome
• Syndactyly, polydactyly, ear lobe syndrome
• Type III short rib polydactyly syndrome
• Type IV short rib polydactyly syndrome

Clinical Information

• Polydactyly

  a congenital anomaly of the hand or foot, marked by the presence of supernumerary digits.

• Short Rib-Polydactyly Syndrome

  a syndrome inherited as an autosomal recessive trait and incompatible with life. the main features are narrow thorax, short ribs, scapular and pelvic dysplasia, and polydactyly.

• Smith-Lemli-Opitz Syndrome

  an autosomal recessive disorder of cholesterol metabolism. it is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. this syndrome is characterized by multiple congenital abnormalities, growth deficiency, and intellectual disability.

• Bilateral Renal Agenesis

  a congenital abnormality characterized by the absence of both kidneys.

• Renal Agenesis

  a congenital abnormality characterized by the absence of one or both kidneys.

• Unilateral Renal Agenesis|Congenital Single Kidney|Congenital Solitary Kidney|Congenital Solitary Kidney

  a congenital abnormality characterized by the presence of only one kidney.

• Multinodular Goiter

  nodular goiter characterized by more than one discrete tissue mass.

• Non-Toxic Multinodular Goiter|Nontoxic multinodular goiter

  a multinodular goiter that is not associated with changes in thyroid function or malignancy.

• Thyrotoxicosis with Toxic Multinodular Goiter with Thyrotoxic Crisis|Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis

  evidence of thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis.

• Thyrotoxicosis with Toxic Multinodular Goiter without Thyrotoxic Crisis|Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis

  evidence of thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis.

• Cortical Blindness

  visual impairment due to visual cortex dysfunction.

• Autosomal Dominant Polycystic Kidney Disease

  polycystic kidney disease inherited in an autosomal dominant pattern. symptoms usually appear at middle age and include abdominal pain, hematuria and high blood pressure. patients may develop brain aneurysms and liver cysts.

• Autosomal Dominant Polycystic Kidney Disease Type 2

  autosomal dominant polycystic kidney disease caused by a mutation in pkd2.

• Autosomal Dominant Polycystic Kidney Disease Type I

  autosomal dominant polycystic kidney disease caused by a mutation in pkd1.

• Polycystic Kidney Disease, Infantile Severe, with Tuberous Sclerosis|Autosomal Dominant Polycystic Kidney Disease Type 1 with Tuberous Sclerosis|PKDTS|TSC2-PKD1 Contiguous Gene Deletion Syndrome

  an autosomal dominant condition caused by a contiguous gene deletion involving the pkd1 and tsc2 genes, encoding polycystin-1 and tuberin respectively. it is characterized by polycystic kidneys and tuberous sclerosis.

• Polycystin-1|Autosomal Dominant Polycystic Kidney Disease Protein 1

  polycystin-1 (4303 aa, ~463 kda) is encoded by the human pkd1 gene. this protein may play a role in protein-protein and protein-carbohydrate interactions during kidney development.

Q69.9 is grouped with Diagnostic Related Groups - MS-DRG Mapping

Diagnostic Related Groups (DRGs) are a classification system used to group together diagnosis codes for the purpose of reimbursement and healthcare management. DRGs are used to standardize the way hospitals and other providers are paid for inpatient services. In this system patients are grouped together based on their principal diagnosis in areas referred to as Major Diagnostic Categories (MDC). Once a patient is assigned a particular diagnostic category, providers receive a predetermined payment rate for the services rendered. This reimbursement rate is often fixed and is meant to cover the cost of care for that patient. Reimbursement is also affected by the relative weight of a diagnostic related group based on the severity of a patient's illness and the associated cost of care during hospitalization.

Diagnostic related groups encourage healthcare providers to focus on quality and efficiency in patient care while managing costs effectively. The diagnosis code is present in the following groups for version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Present on Admission (POA)

Q69.9 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

Convert Q69.9 to ICD-9-CM

• ICD-9-CM Code: 755.00 - Polydactyly NOS
  Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Code History

• FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.